Literature DB >> 27732039

Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis.

Elayne Ahern1, Maria Semkovska1.   

Abstract

OBJECTIVE: Cognitive deficits are frequently observed in major depression. Yet, when these deficits emerge and how they relate to the depressed state is unclear. The aim of this 2-part systematic review and meta-analysis is to determine the pattern and extent of cognitive deficits during a first-episode of depression (FED) and their persistence following FED remission.
METHOD: Published, peer-reviewed articles on cognitive function in FED patients through October 2015 were searched. Meta-analyses with random-effects modeling were conducted. Part 1 assessed weighted, mean effect sizes of cognitive function in FED patients relative to healthy controls. Moderator analyses of clinical and demographical variables effects were conducted. Part 2 assessed weighted, mean effect sizes of change in cognitive function at remission compared with acute FED performance in longitudinal studies.
RESULTS: Thirty-one studies including 994 FED patients were retained in Part 1. Relative to healthy controls, small to large impairments were observed across most cognitive domains. Remission was associated with a normalization of function in processing speed, learning and memory, autobiographical memory, shifting, and IQ. Lower FED age was associated with higher IQ, but more impairment in word-list delayed memory. Four studies including 92 FED patients were retained in Part 2. Following remission, FED patients showed small improvements in processing speed and shifting but persistent impairment in inhibition and verbal fluency.
CONCLUSION: Significant cognitive deficits are already identifiable during a FED, with some functions showing persistent impairment upon remission. Clinicians must consider cognitive impairment alongside mood symptoms to ensure functional recovery from the FED. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27732039     DOI: 10.1037/neu0000319

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  59 in total

1.  Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness.

Authors:  Milena Radoman; Susanne S Hoeppner; Randi M Schuster; A Eden Evins; Jodi M Gilman
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

2.  Early childhood depression, emotion regulation, episodic memory, and hippocampal development.

Authors:  Deanna M Barch; Michael P Harms; Rebecca Tillman; Elizabeth Hawkey; Joan L Luby
Journal:  J Abnorm Psychol       Date:  2019-01

Review 3.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

Review 4.  A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression.

Authors:  Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

5.  The Effects of Major Depressive Disorder on the Sequential Organization of Information Processing Stages: An Event-Related Potential Study.

Authors:  Daniel Kwasi Ahorsu; Ken Chung; Ho Hon Wong; Michael Gar Chung Yiu; Yat Fung Mok; Ka Shun Lei; Hector Wing Hong Tsang
Journal:  Brain Sci       Date:  2020-12-04

6.  Neuropsychological predictors of response to cognitive behavioral therapy for posttraumatic stress disorder in persons with severe mental illness.

Authors:  Kim T Mueser; Susan R McGurk; Haiyi Xie; Elisa E Bolton; M Kay Jankowski; Weili Lu; Stanley D Rosenberg; Rosemarie Wolfe
Journal:  Psychiatry Res       Date:  2017-10-06       Impact factor: 3.222

Review 7.  Treating major depression and comorbid disorders with transcranial magnetic stimulation.

Authors:  Lauren Thompson
Journal:  J Affect Disord       Date:  2020-07-15       Impact factor: 4.839

8.  Investigating whether depressed youth exhibiting elevated C reactive protein perform worse on measures of executive functioning, verbal fluency and episodic memory in a large, population based sample of Dutch adolescents.

Authors:  Naoise Mac Giollabhui; Lauren B Alloy; Catharina A Hartman
Journal:  Brain Behav Immun       Date:  2020-09-02       Impact factor: 7.217

Review 9.  Down and High: Reflections Regarding Depression and Cannabis.

Authors:  Catherine Langlois; Stéphane Potvin; Atul Khullar; Smadar Valérie Tourjman
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

Review 10.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.